siRNA therapeutics for cancer (Samyang)

N/A

Report date: 2025/06/11 10:58:44
NME

Base Information

Drug NamesiRNA therapeutics for cancer (Samyang)
Drug Alias NamesiRNA-PMB-6036B-6061
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSamyang Corp
China Registration ClassN/A

Develop Information

Active CompaniesSamyang Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A